[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN106554352B - Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof - Google Patents

Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof Download PDF

Info

Publication number
CN106554352B
CN106554352B CN201510639887.3A CN201510639887A CN106554352B CN 106554352 B CN106554352 B CN 106554352B CN 201510639887 A CN201510639887 A CN 201510639887A CN 106554352 B CN106554352 B CN 106554352B
Authority
CN
China
Prior art keywords
naphthyridine
aromatic hydrocarbon
formula
naphthalen
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510639887.3A
Other languages
Chinese (zh)
Other versions
CN106554352A (en
Inventor
范洪涛
李银奎
邵爽
任雪艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Eternal Material Technology Co Ltd
Guan Eternal Material Technology Co Ltd
Original Assignee
Beijing Eternal Material Technology Co Ltd
Guan Eternal Material Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Eternal Material Technology Co Ltd, Guan Eternal Material Technology Co Ltd filed Critical Beijing Eternal Material Technology Co Ltd
Priority to CN201510639887.3A priority Critical patent/CN106554352B/en
Publication of CN106554352A publication Critical patent/CN106554352A/en
Application granted granted Critical
Publication of CN106554352B publication Critical patent/CN106554352B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/626Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a polycyclic aromatic hydrocarbon derivative containing naphthyridine groups, which has a structure shown as a formula (1). The polycyclic aromatic hydrocarbon derivative containing naphthyridine groups is suitable for being used as an ETL material in an electroluminescent display. The use of the material can effectively reduce the working voltage of the organic electroluminescent device and improve the luminous efficiency of the organic electroluminescent device.
Figure DDA0000815470300000011

Description

Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof
Technical Field
The invention belongs to the field of organic electroluminescence, and particularly relates to a naphthyridine group-containing polycyclic aromatic hydrocarbon derivative, an intermediate thereof, a preparation method thereof and application thereof in an electron transport material.
Background
The electron transport material traditionally used in electroluminescent devices is Alq3However, Alq3Has a low electron mobility ratio (approximately at 10)-6cm2Vs). In order to improve the electron transport properties of electroluminescent devices, researchers have made a great deal of exploratory work.
LG chemistry in chinese patent specification CN 101003508A reports a series of pyrene derivatives as electron transporting and injecting materials in electroluminescent devices to improve the luminous efficiency of the devices. FFF-Blm4 (J.Am.chem.Soc.; (Communication); 2008; 130 (11); 3282-. Kodak in U.S. patents (publication nos. US 2006/0204784 and US 2007/0048545) mentioned a hybrid electron transport layer formed by doping one material with a low LUMO level material with another electron transport material with a low device operating voltage and other materials such as metallic materials. Devices based on such hybrid electron transport layers provide improved device efficiency, but increase the complexity of the device fabrication process, which is detrimental to OLED cost reduction. The stable and efficient electron transport material and/or electron injection material are/is developed, so that the device lighting and working voltage is reduced, the device efficiency is improved, the device service life is prolonged, and the method has important practical application value.
Disclosure of Invention
The invention aims to provide a novel polycyclic aromatic hydrocarbon derivative containing naphthyridine groups, which can be used in the field of organic electroluminescent display. In particular, the compounds can be used as electron transport materials in organic electroluminescent displays.
The use of the material can effectively reduce the working voltage of the organic electroluminescent device and improve the luminous efficiency of the organic electroluminescent device.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
a polycyclic aromatic hydrocarbon derivative containing naphthyridine groups has a structure shown as a formula (1):
Figure BDA0000815470280000021
wherein: ar is selected from C10-C50A fused ring aromatic hydrocarbon group or a fused heterocyclic aromatic hydrocarbon group;
l may be a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted heterocyclylene group.
R1And R2The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group or condensed heterocyclic aromatic hydrocarbonA substituted or unsubstituted alkyl group, a cyano group.
The Ar is preferably a group represented by the formula (2) to the formula (7):
Figure BDA0000815470280000022
in the above formulae (2) to (7), Ar1And Ar2Same or different, each independently selected from H, C4-C30Aromatic ring group of (A), C4-C30Heteroaryl ring radical of (2), C4-C30With a condensed ring aromatic hydrocarbon group or C4-C30A fused heterocyclic aromatic hydrocarbon group of (a);
R4to R13The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group, or condensed heterocyclic aromatic hydrocarbon group, substituted or unsubstituted alkyl and cyano.
Preferably, the naphthyridine group-containing fused ring aromatic hydrocarbon derivative has a structure represented by (8) to formula (11):
Figure BDA0000815470280000023
Figure BDA0000815470280000031
in the above formulae (7) to (11), Ar1And Ar2Same or different, each independently selected from H, C4-C30Aromatic ring group of (A), C4-C30Heteroaryl ring radical of (2), C4-C30With a condensed ring aromatic hydrocarbon group or C4-C30A fused heterocyclic aromatic hydrocarbon group of (a);
l is a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted heterocyclylene group.
R4To R13The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group, or condensed heterocyclic aromatic hydrocarbon group, substituted or unsubstituted alkyl and cyano.
The substituted or unsubstituted aromatic hydrocarbon group is phenyl, o-tolyl, p-tolyl or tert-butylphenyl; the substituted or unsubstituted heterocyclic aromatic hydrocarbon group is furan, benzofuran, dibenzofuran, thiophene, benzothiophene, dibenzothiophene, carbazole, pyridine, pyrazine, 2.4-methyl-1.3.5 triazine or 4.6 diphenylpyrimidine; the substituted or unsubstituted condensed ring aromatic hydrocarbon group is naphthyl, phenanthryl, anthryl, pyrenyl,
Figure BDA0000815470280000033
A fluorenyl, triphenylene, or 9, 9-dimethyl-2-fluorenyl group; the substituted or unsubstituted fused heterocyclic aromatic hydrocarbon group is quinoline, isoquinoline or quinazoline; the unsubstituted alkyl group is a methyl group, and the substituted alkyl group is a trifluoromethyl group. The substitution may be mono-or polysubstituted.
Preferably, the compound is of the formula (14) to (56):
Figure BDA0000815470280000032
Figure BDA0000815470280000041
Figure BDA0000815470280000051
Figure BDA0000815470280000061
the application of the polycyclic aromatic hydrocarbon derivative containing the naphthyridine group in an organic electroluminescent device.
The polycyclic aromatic hydrocarbon derivative containing the naphthyridine group can be used as an electron transport material.
An organic electroluminescent device comprises a substrate, and an anode layer, an organic light-emitting functional layer and a cathode layer which are sequentially formed on the substrate; the organic light-emitting functional layer comprises a hole transport layer, an organic light-emitting layer and an electron transport layer, and the electron transport material of the electron transport layer is the polycyclic aromatic hydrocarbon derivative containing the naphthyridine group.
Compared with the prior art, the polycyclic aromatic hydrocarbon derivative containing the naphthyridine group has the advantages that:
the condensed ring aromatic hydrocarbon derivative of the quinoxaline group belongs to a typical electron-deficient system, and has suitable HOMO and LUMO energy levels, so that the condensed ring aromatic hydrocarbon derivative has good electron accepting capacity. The condensed ring aromatic hydrocarbon system which is coplanar in a space structure has good electron transfer capability. Therefore, the benzacridine compound is an excellent electron transport material.
Experiments show that when the condensed ring aromatic hydrocarbon derivative of the quinoxaline group is used as an electron transmission material, compared with Bphen which is used as the electron transmission material, the driving voltage of a device is reduced, the working voltage of the device is effectively reduced, the lumen efficiency is improved, the power consumption of the device is reduced, and the condensed ring aromatic hydrocarbon derivative is an electron transmission material with good performance.
Drawings
FIG. 1 is a nuclear magnetic spectrum of a compound represented by the formula (15) ((1HNMR);
FIG. 2 is a nuclear magnetic spectrum of a compound represented by the formula (25) ((1HNMR);
FIG. 3 is a nuclear magnetic spectrum of a compound represented by the formula (33) ((1HNMR);
FIG. 4 is a nuclear magnetic spectrum of a compound represented by the formula (38) ((1HNMR);
FIG. 5 is a nuclear magnetic spectrum of a compound represented by the formula (47) (47)1HNMR);
FIG. 6 is a nuclear magnetic spectrum of a compound represented by the formula (52) ((1HNMR)。
Detailed Description
The basic raw materials used in the present invention include, for example, various brominated derivatives of anthracene, brominated derivatives of diphenylbenzofluoranthene, brominated derivatives of triphenylene, and various brominated derivatives of triphenylene
Figure BDA0000815470280000071
Bromo derivative of (5)Or can be bought in various chemical raw material markets in China or can be synthesized by a common method in a laboratory. These bromides can be prepared into corresponding boric acid compounds by a common method. The 3, 7-dibromo-1, 5-naphthyridine can be conveniently purchased in chemical markets.
The invention provides a polycyclic aromatic hydrocarbon derivative containing naphthyridine groups, which has a structure shown as a formula (1):
Figure BDA0000815470280000072
wherein: ar is selected from C10-C50A fused ring aromatic hydrocarbon group or a fused heterocyclic aromatic hydrocarbon group;
l may be a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted heterocyclylene group.
R1And R2The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group, or condensed heterocyclic aromatic hydrocarbon group, substituted or unsubstituted alkyl and cyano.
The Ar is preferably a group represented by the formula (2) to the formula (7):
Figure BDA0000815470280000073
in the above formulae (2) to (7), Ar1And Ar2Same or different, each independently selected from H, C4-C30Aromatic ring group of (A), C4-C30Heteroaryl ring radical of (2), C4-C30With a condensed ring aromatic hydrocarbon group or C4-C30A fused heterocyclic aromatic hydrocarbon group of (a);
R4to R13The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group, or condensed heterocyclic aromatic hydrocarbon group, substituted or unsubstituted alkyl and cyano.
Preferably, the naphthyridine group-containing fused ring aromatic hydrocarbon derivative has a structure represented by (8) to formula (11):
Figure BDA0000815470280000081
in the above formulae (7) to (11), Ar1And Ar2Same or different, each independently selected from H, C4-C30Aromatic ring group of (A), C4-C30Heteroaryl ring radical of (2), C4-C30With a condensed ring aromatic hydrocarbon group or C4-C30A fused heterocyclic aromatic hydrocarbon group of (a);
l is a single bond, a substituted or unsubstituted arylene group, a substituted or unsubstituted heterocyclylene group.
R4To R13The same or different, are respectively and independently selected from H, aromatic hydrocarbon group, heterocyclic aromatic hydrocarbon group, condensed ring aromatic hydrocarbon group, or condensed heterocyclic aromatic hydrocarbon group, substituted or unsubstituted alkyl and cyano.
The substituted or unsubstituted aromatic hydrocarbon group is phenyl, o-tolyl, p-tolyl or tert-butylphenyl; the substituted or unsubstituted heterocyclic aromatic hydrocarbon group is furan, benzofuran, dibenzofuran, thiophene, benzothiophene, dibenzothiophene, carbazole, pyridine, pyrazine, 2.4-methyl-1.3.5 triazine or 4.6 diphenylpyrimidine; the substituted or unsubstituted condensed ring aromatic hydrocarbon group is naphthyl, phenanthryl, anthryl, pyrenyl,
Figure BDA0000815470280000083
A fluorenyl, triphenylene, or 9, 9-dimethyl-2-fluorenyl group; the substituted or unsubstituted fused heterocyclic aromatic hydrocarbon group is quinoline, isoquinoline or quinazoline; the unsubstituted alkyl group is a methyl group, and the substituted alkyl group is a trifluoromethyl group. The substitution may be mono-or polysubstituted.
Preferably, the compound is of the formula (14) to (56):
Figure BDA0000815470280000082
Figure BDA0000815470280000091
Figure BDA0000815470280000101
Figure BDA0000815470280000111
the application of the polycyclic aromatic hydrocarbon derivative containing the naphthyridine group in an organic electroluminescent device.
The polycyclic aromatic hydrocarbon derivative containing the naphthyridine group can be used as an electron transport material.
An organic electroluminescent device comprises a substrate, and an anode layer, an organic light-emitting functional layer and a cathode layer which are sequentially formed on the substrate; the organic light-emitting functional layer comprises a hole transport layer, an organic light-emitting layer and an electron transport layer, and the electron transport material of the electron transport layer is the polycyclic aromatic hydrocarbon derivative containing the naphthyridine group.
EXAMPLE 1 Synthesis of various 3-bromo-7-aryl-1, 5-naphthyridine derivative intermediates
Synthesis of 1, 3-bromo-7-phenyl-1, 5-naphthyridine
Figure BDA0000815470280000121
A1000 ml three-neck flask is stirred by magnetic force and protected by nitrogen, 5.72g (286, 0.02mol) of 3, 7-dibromo-1, 5-naphthyridine, 2.7g (122, 0.022mol) of phenylboronic acid, 1.16g (1154, 0.001mol) of tetrakis ((triphenylphosphine) palladium), 80ml of 2M aqueous sodium carbonate solution, 80ml of toluene, 80ml of ethanol and argon are added for replacement, the mixture is refluxed at 80 ℃, the reaction is monitored by a Thin Layer Chromatography (TLC) method, after 4 hours, TLC finds that the reaction of the dibromide serving as the raw material is complete and only the monobromide product is generated, the temperature is reduced to 25 ℃, an organic layer is separated, evaporated to dryness, column chromatography separation is carried out, ethyl acetate/petroleum ether is leached, and 5.77g of target intermediate 3-bromo-7-phenyl-1, 5-naphthyridine is obtained, the molecular weight is 284.3% of yield.
Synthesis of 2, 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine
Figure BDA0000815470280000122
The reaction steps are the same as the synthesis of the 3-bromo-7-phenyl-1, 5-naphthyridine, except that the raw material phenylboronic acid is changed into naphthalene-1-boronic acid to obtain the intermediate 3-bromo-7- (naphthalene-1-yl) -1, 5-naphthyridine.
Synthesis of 3, 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine
Figure BDA0000815470280000123
The reaction steps are the same as the synthesis of the 3-bromo-7-phenyl-1, 5-naphthyridine, except that the raw material phenylboronic acid is changed into naphthalene-2-boronic acid to obtain the intermediate 3-bromo-7- (naphthalene-2-yl) -1, 5-naphthyridine.
Example 2
Synthesis of Compound represented by the formula (14)
Figure BDA0000815470280000124
A1000 ml jar was equipped with magnetic stirring, and 3-bromo-7-phenyl-1, 5-naphthyridine 5.68g (molecular weight 284, 0.02mol), 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid 11.0g (molecular weight 474, 0.022mol), tetrakis ((triphenylphosphine) palladium 1.16g (molecular weight 1154, 0.001mol), 2M aqueous sodium carbonate 80ml, toluene 80ml, ethanol 80ml, argon replacement, reflux at 80 deg.C, monitoring the reaction by Thin Layer Chromatography (TLC), after 3.5 hours TLC found that the starting bromide reacted completely, only the product spot was reduced, the organic layer was separated, evaporated to dryness, column chromatography was performed, ethyl acetate/petroleum ether elution provided 11.33g of the compound of formula (14), molecular weight 634, yield 89.3%.
Product MS (m/e): 634, elemental analysis (C)48H30N2): theoretical value C: 90.82%, H: 4.76%, N: 4.41 percent; found value C: 90.85%, H: 4.72%, N: 4.43 percent.
Example 3
Synthesis of Compound represented by the formula (15)
The procedure was as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine and the other reagents were changed to give a compound represented by formula (15).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.23%, H: 4.73%, N: 4.04% of its nuclear magnetic spectrum (1HNMR) is shown in fig. 1.
Example 4
Synthesis of Compound represented by the formula (16)
The procedure was as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine and the other reagents were changed to give a compound represented by formula (16).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.21%, H: 4.74%, N: 4.05 percent.
Example 5
Synthesis of Compound represented by the formula (17)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 9- (naphthalen-2-yl) anthracene-10-boronic acid, and the other reagents were changed to give a compound represented by formula (17).
Product MS (m/e): 558 elemental analysis (C)42H26N2): theoretical value C: 90.29%, H: 4.69%, N: 5.01 percent; found value C: 90.31%, H: 4.65%, N: 5.04 percent.
Example 6
Synthesis of Compound represented by the formula (18)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 9- (naphthalen-2-yl) anthracene-10-boronic acid, and the other reagents were changed to give a compound represented by formula (18).
Product MS (m/e): 558, yuanElemental analysis (C)42H26N2): theoretical value C: 90.29%, H: 4.69%, N: 5.01 percent; found value C: 90.32%, H: 4.66%, N: 5.02 percent.
Example 7
Synthesis of Compound represented by the formula (19)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to p- (9- (naphthalen-2-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (19).
Product MS (m/e): 634, elemental analysis (C)48H30N2): theoretical value C: 90.82%, H: 4.76%, N: 4.41 percent; found value C: 90.84%, H: 4.73%, N: 4.43 percent.
Example 8
Synthesis of Compound represented by the formula (20)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to p- (9- (naphthalen-2-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (20).
Product MS (m/e): 634, elemental analysis (C)48H30N2): theoretical value C: 90.82%, H: 4.76%, N: 4.41 percent; found value C: 90.84%, H: 4.73%, N: 4.43 percent.
Example 9
Synthesis of Compound represented by the formula (21)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 9- (naphthalen-1-yl) anthracene-10-boronic acid, and the other reagents were changed to give a compound represented by formula (21).
Product MS (m/e): 558 elemental analysis (C)42H26N2): theoretical value C: 90.29%, H: 4.69%, N: 5.01 percent; found value C: 90.31%, H: 4.65%, N: 5.04 percent.
Example 10
Synthesis of Compound represented by the formula (22)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-1-yl) anthracene-2-boronic acid to 9- (naphthalen-1-yl) anthracene-10-boronic acid, and the other reagents were changed to give a compound represented by formula (22).
Product MS (m/e): 558 elemental analysis (C)42H26N2): theoretical value C: 90.29%, H: 4.69%, N: 5.01 percent; found value C: 90.27%, H: 4.68%, N: 5.05 percent.
Example 11
Synthesis of Compound represented by the formula (23)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to p- (9- (naphthalen-1-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (23).
Product MS (m/e): 634, elemental analysis (C)48H30N2): theoretical value C: 90.82%, H: 4.76%, N: 4.41 percent; found value C: 90.83%, H: 4.74%, N: 4.43 percent.
Example 12
Synthesis of Compound represented by the formula (24)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to p- (9- (naphthalen-1-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (24).
Product MS (m/e): 634, elemental analysis (C)48H30N2): theoretical value C: 90.82%, H: 4.76%, N: 4.41 percent; found value C: 90.85%, H: 4.73%, N: 4.42 percent.
Example 13
Synthesis of Compound represented by the formula (25)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to p- (9- (9, 9-dimethyl-9H-fluoren-2-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give the compound represented by formula (25).
Product MS (m/e): 700, elemental analysis (C)53H36N2): theoretical value C: 90.83%, H: 5.18%, N: 4.00 percent; found value C: 90.85%, H: 5.12%, N: 4.03% of its nuclear magnetic spectrum (1HNMR) is shown in fig. 2.
Example 14
Synthesis of Compound represented by the formula (26)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to p- (9- (9, 9-dimethyl-9H-fluoren-2-yl) anthracen-10-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (26).
Product MS (m/e): 700, elemental analysis (C)53H36N2): theoretical value C: 90.83%, H: 5.18%, N: 4.00 percent; found value C: 90.81%, H: 5.14%, N: 4.05 percent.
Example 15
Synthesis of Compound represented by the formula (27)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 9- (9, 9-dimethyl-9H-fluoren-2-yl) anthracene-10-boronic acid, and the other reagents were changed to give a compound represented by formula (27).
Product MS (m/e): 624, elemental analysis (C)47H32N2): theoretical value C: 90.35%, H: 5.16%, N: 4.48 percent; found value C: 90.37%, H: 5.13%, N: 4.50 percent.
Example 16
Synthesis of Compound represented by the formula (28)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 9- (9, 9-dimethyl-9H-fluoren-2-yl) anthracene-10-boronic acid, and the other reagents were changed to give the compound represented by formula (28).
Product MS (m/e): 624, elemental analysis (C)47H32N2): theoretical value C: 90.35%, H: 5.16%, N: 4.48 percent; found value C: 90.33%, H: 5.15%, N: 4.52 percent.
Example 17
Synthesis of Compound represented by the formula (29)
The synthesis procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid was changed to anthracene-9, 10-diboronic acid, and the other reagents were unchanged to obtain a compound represented by formula (29).
Product MS (m/e): 686 elemental analysis (C)47H32N2): theoretical value C: 87.44%, H: 4.40%, N: 8.16 percent; found value C: 87.42%, H: 4.44%, N: 8.14 percent.
Example 18
Synthesis of Compound represented by the formula (30)
The synthesis procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid was changed to anthracene-9, 10-diboronic acid, and the other reagents were unchanged to obtain the compound represented by formula (30).
Product MS (m/e): 686 elemental analysis (C)47H32N2): theoretical value C: 87.44%, H: 4.40%, N: 8.16 percent; found value C: 87.45%, H: 4.42%, N: 8.13 percent.
Example 19
Synthesis of Compound represented by the formula (31)
The procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine as a starting material was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 7, 12-diphenylbenzo [ k ] fluoranthene-3-boronic acid, and the other reagents were changed to give a compound represented by formula (31).
Product MS (m/e): 658 elemental analysis (C)50H30N2): theoretical value C: 91.16%, H: 4.59%, N: 4.25 percent; found value C: 91.14%, H: 4.62%, N: 4.24 percent.
Example 20
Synthesis of Compound represented by the formula (32)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 7, 12-diphenylbenzo [ k ] fluoranthene-3-boronic acid, and the other reagents were changed to give a compound represented by formula (32).
Product MS (m/e): 658 elemental analysis (C)50H30N2): theoretical value C: 91.16%, H: 4.59%, N: 4.25 percent; found value C: 91.13%, H: 4.61%, N: 4.26 percent.
Example 21
Synthesis of Compound represented by the formula (33)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to p- (7, 12-diphenylbenzo [ k ] fluoranthen-3-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (33).
Product MS (m/e): 734, elemental analysis (C)56H34N2): theoretical value C: 91.52%, H: 4.66%, N: 3.81 percent; found value C: 91.54%, H: 4.63%, N: 3.83% of its nuclear magnetic spectrum (1HNMR) is shown in fig. 3.
Example 22
Synthesis of Compound represented by the formula (34)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to p- (7, 12-diphenylbenzo [ k ] fluoranthen-3-yl) phenylboronic acid, and the other reagents were changed to give a compound represented by formula (34).
Product MS (m/e): 734, elemental analysis (C)56H34N2): theoretical value C: 91.52%, H: 4.66%, N: 3.81 percent; found value C: 91.50%, H: 4.64%, N: 3.86 percent.
Example 23
Synthesis of Compound represented by the formula (35)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12-naphthalenyl
Figure BDA0000815470280000171
-6-boronic acid, with the other reagents unchanged, to give the compound of formula (35).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.75%, H: 4.62%, N: 4.63 percent.
Example 24
Synthesis of Compound represented by the formula (36)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12- (naphthalen-2-yl)
Figure BDA0000815470280000172
-6-boronic acid, and the other reagents are unchanged to give the compound represented by formula (36).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.73%, H: 4.63%, N: 4.64 percent.
Example 25
Synthesis of Compound represented by the formula (37)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12- (naphthalen-1-yl)
Figure BDA0000815470280000181
-6-boronic acid, with the other reagents unchanged, to give the compound of formula (37).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.75%, H: 4.62 percent of the total weight of the steel,N:4.63%。
example 26
Synthesis of Compound represented by the formula (38)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12- (naphthalen-1-yl)
Figure BDA0000815470280000182
-6-boronic acid, with the other reagents unchanged, to give the compound represented by formula (38).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.77%, H: 4.61%, N: 4.62% of its nuclear magnetic spectrum (1HNMR) is shown in fig. 4.
Example 27
Synthesis of Compound represented by the formula (39)
The procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine as the starting material was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12- (9, 9-dimethyl-9H-fluoren-2-yl)
Figure BDA0000815470280000183
-6-boronic acid, and the other reagents are unchanged to obtain the compound represented by the formula (39).
Product MS (m/e): 674, elemental analysis (C)51H34N2): theoretical value C: 90.77%, H: 5.08%, N: 4.15 percent; found value C: 90.74%, H: 5.07%, N: 4.19 percent.
Example 28
Synthesis of Compound represented by the formula (40)
The procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine as the starting material was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 12- (9, 9-dimethyl-9H-fluoren-2-yl)
Figure BDA0000815470280000184
-6-boronic acid, with the other reagents unchanged, to give the formula(40) The compounds shown.
Product MS (m/e): 674, elemental analysis (C)51H34N2): theoretical value C: 90.77%, H: 5.08%, N: 4.15 percent; found value C: 90.75%, H: 5.07%, N: 4.18 percent.
Example 29
Synthesis of Compound represented by the formula (41)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, was changed to p- (12- (naphthalen-2-yl)
Figure BDA0000815470280000185
-6-yl) phenylboronic acid with the remaining reagents unchanged to give the compound of formula (41).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.22%, H: 4.74%, N: 4.04 percent.
Example 30
Synthesis of Compound represented by the formula (42)
The procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, and 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, was changed to p- (12- (naphthalen-2-yl)
Figure BDA0000815470280000191
-6-yl) phenylboronic acid with the remaining reagents unchanged to give the compound of formula (42).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.24%, H: 4.73%, N: 4.03 percent.
Example 31
Synthesis of Compound represented by the formula (43)
The procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine as the starting material was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 6- (naphthalen-2-yl) pyrene-1-boronic acid, and the other reagents were changed to give the compound represented by formula (43).
Product MS (m/e): 582, elemental analysis (C)44H26N2): theoretical value C: 90.69%, H: 4.50%, N: 4.81 percent; found value C: 90.64%, H: 4.52%, N: 4.83 percent.
Example 32
Synthesis of Compound represented by the formula (44)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 6- (naphthalen-2-yl) pyrene-1-boronic acid, and the other reagents were unchanged to give the compound represented by formula (44).
Product MS (m/e): 582, elemental analysis (C)44H26N2): theoretical value C: 90.69%, H: 4.50%, N: 4.81 percent; found value C: 90.67%, H: 4.51%, N: 4.82 percent.
Example 33
Synthesis of Compound represented by the formula (45)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid to 6- (naphthalen-1-yl) pyrene-1-boronic acid, and the other reagents were unchanged to give the compound represented by formula (45).
Product MS (m/e): 582, elemental analysis (C)44H26N2): theoretical value C: 90.69%, H: 4.50%, N: 4.81 percent; found value C: 90.63%, H: 4.53%, N: 4.84 percent.
Example 34
Synthesis of Compound represented by the formula (46)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to 6- (naphthalen-1-yl) pyrene-1-boronic acid, and the other reagents were unchanged to give the compound represented by formula (46).
Product MS (m/e): 582, elemental analysis (C)44H26N2): theoretical value C: 90.69%, H: 4.50%, N: 4.81 percent; measured valueC:90.64%,H:4.51%,N:4.85%。
Example 35
Synthesis of Compound represented by the formula (47)
The synthesis procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid was changed to 6- (9, 9-dimethyl-9H-fluoren-2-yl) pyrene-1-boronic acid, and the other reagents were changed to obtain the compound represented by formula (47).
Product MS (m/e): 648 elemental analysis (C)49H32N2): theoretical value C: 90.71%, H: 4.97%, N: 4.32 percent; found value C: 90.73%, H: 4.93%, N: 4.34 percent.
Example 36
Synthesis of Compound represented by the formula (48)
The synthesis procedure was the same as in example 2 except that 3-bromo-7-phenyl-1, 5-naphthyridine was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid was changed to 6- (9, 9-dimethyl-9H-fluoren-2-yl) pyrene-1-boronic acid, and the other reagents were changed to obtain the compound represented by formula (48).
Product MS (m/e): 648 elemental analysis (C)49H32N2): theoretical value C: 90.71%, H: 4.97%, N: 4.32 percent; found value C: 90.74%, H: 4.93%, N: 4.33 percent.
Example 37
Synthesis of Compound represented by the formula (49)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, was changed to p- (6- (naphthalen-2-yl) pyrene-1-yl) phenylboronic acid, and the other reagents were changed to give the compound represented by formula (49).
Product MS (m/e): 658 elemental analysis (C)50H30N2): theoretical value C: 91.16%, H: 4.59%, N: 4.25 percent; found value C: 91.14%, H: 4.57%, N: 4.29% of its nuclear magnetic spectrum (1HNMR) is shown in fig. 5.
Example 38
Synthesis of Compound represented by the formula (50)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, was changed to p- (6- (naphthalen-2-yl) pyrene-1-yl) phenylboronic acid, and the other reagents were unchanged to give the compound represented by formula (50).
Product MS (m/e): 658 elemental analysis (C)50H30N2): theoretical value C: 91.14%, H: 4.57%, N: 4.29 percent; found value C: 91.16%, H: 4.58%, N: 4.26 percent.
Example 39
Synthesis of Compound represented by the formula (51)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, was changed to p- (6- (naphthalen-2-yl) pyrene-1-yl) phenylboronic acid, and the other reagents were changed to give the compound represented by formula (51).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.23%, H: 4.73%, N: 4.04 percent.
Example 40
Synthesis of Compound represented by the formula (52)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to p- (7- (naphthalen-2-yl) triphenylen-2-yl) phenylboronic acid, and the conditions for other drugs, reagents, reactions, separations, and the like were unchanged to obtain the compound represented by formula (52).
Product MS (m/e): 684 elemental analysis (C)52H32N2): theoretical value C: 91.20%, H: 4.71%, N: 4.09%; found value C: 91.22%, H: 4.73%, N: 4.05%, its nuclear magnetic spectrum (1HNMR) is shown in fig. 6.
EXAMPLE 41
Synthesis of Compound represented by the formula (53)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-2-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to 7- (naphthalen-2-yl) triphenylene-2-boronic acid, and the conditions for other drugs, reagents, reactions, separations, and the like were unchanged to give the compound represented by formula (53).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.72%, H: 4.65%, N: 4.63 percent.
Example 42
Synthesis of Compound represented by the formula (54)
The synthesis procedure was the same as in example 2 except that the starting material, 3-bromo-7-phenyl-1, 5-naphthyridine, was changed to 3-bromo-7- (naphthalen-1-yl) -1, 5-naphthyridine, 9, 10-di (naphthalen-2-yl) anthracene-2-boronic acid, to 7- (naphthalen-2-yl) triphenylene-2-boronic acid, and the conditions for other drugs, reagents, reactions, separations, and the like were unchanged to give the compound represented by formula (54).
Product MS (m/e): 608, elemental analysis (C)46H28N2): theoretical value C: 90.76%, H: 4.64%, N: 4.60 percent; found value C: 90.73%, H: 4.65%, N: 4.62 percent.
The following are examples of the use of the compounds of the invention:
example 43
To facilitate comparison of the transport properties of these electron transport materials, the present inventors designed a simple electroluminescent device using EM1 as the emissive material (EM1 is the host material and not the emissive material in order not to pursue high efficiency but to verify the possibility of these materials being practical) and using the high efficiency electron transport material Bphen as the comparative material. The structures of EM1 and Bphen are:
Figure BDA0000815470280000221
the structure of the organic electroluminescent device in the embodiment of the invention is as follows:
substrate/anode/Hole Transport Layer (HTL)/organic light Emitting Layer (EL)/Electron Transport Layer (ETL)/cathode.
The substrate may be a substrate used in a conventional organic light emitting device, for example: glass or plastic. In the invention, the glass substrate and the ITO are used as anode materials in the manufacture of the organic electroluminescent device.
Various triarylamine-based materials may be used for the hole transport layer. The hole transport material selected for use in the fabrication of the organic electroluminescent device of the present invention is NPB. The NPB structure is:
Figure BDA0000815470280000222
the cathode can adopt a metal and a mixture structure thereof, such as Mg: ag. Ca: ag, etc., or an electron injection layer/metal layer structure, such as LiF/Al, Li2O/Al and the like. The cathode material selected in the preparation of the organic electroluminescent device is LiF/Al.
The compound in this embodiment is used as an electron transport material in an organic electroluminescent device, and the EML is used as a light emitting layer material, so that a plurality of organic electroluminescent devices are prepared, and the structure of each organic electroluminescent device is as follows: ITO/NPB (40nm)/EM1(30nm)/ETL material (20nm)/LiF (0.5nm)/Al (150 nm);
in one comparative organic electroluminescent device, Bphen was used as the electron transport material, and the materials of the present invention were used for the remaining organic electroluminescent devices.
The preparation process of the organic electroluminescent device in the embodiment is as follows:
the glass plate coated with the ITO transparent conductive layer was sonicated in a commercial detergent, rinsed in deionized water, washed in acetone: ultrasonically removing oil in an ethanol mixed solvent, baking in a clean environment until the water is completely removed, cleaning by using ultraviolet light and ozone, and bombarding the surface by using low-energy cationic beams;
placing the glass substrate with the anode in a vacuum chamber, and vacuumizing to 1 × 10-5~9×10-3Pa, performing vacuum evaporation on the anode layer film to form NPB as a hole transport layer, wherein the evaporation rate is 0.1nm/s, and the evaporation film thickness is 40 nm;
vacuum evaporating EM1 on the hole transport layer to serve as a light emitting layer of the device, wherein the evaporation rate is 0.1nm/s, and the total film thickness of the evaporation is 30 nm;
a compound represented by a one-layer type (14), a formula (15), a formula (18), a formula (22), a formula (27), a formula (29), a formula (31), a formula (36), a formula (43) or a formula (53) is vacuum-evaporated on the light-emitting layer to be used as an electron transport layer material of the device, Bphen is used as a contrast material of the electron transport layer material of the device, the evaporation rate is 0.1nm/s, and the total thickness of the evaporated film is 20 nm;
LiF with the thickness of 0.5nm is vacuum-evaporated on the Electron Transport Layer (ETL) to be used as an electron injection layer, and an Al layer with the thickness of 150nm is used as a cathode of the device.
The organic electroluminescent device properties are given in the following table:
compound numbering Required luminance cd/m2 Voltage V Current efficiency cd/A
Bphen 1000.00 6.2 6.1
Formula (14) 1000.00 5.6 7.1
Formula (15) 1000.00 5.6 6.9
Formula (18) 1000.00 5.7 7.0
Formula (22) 1000.00 5.8 7.0
Formula (27) 1000.00 5.7 7.1
Formula (29) 1000.00 5.7 6.9
Formula (31) 1000.00 5.6 7.1
Formula (36) 1000.00 5.7 7.1
Formula (43) 1000.00 5.7 7.0
Formula (53) 1000.00 5.7 7.1
The results show that the novel organic material is used for the organic electroluminescent device, can effectively reduce the working voltage of the device and improve the current efficiency, and is an electron transport material with good performance. Although the invention has been described in connection with the embodiments, the invention is not limited to the embodiments described above, and it should be understood that various modifications and improvements can be made by those skilled in the art within the spirit of the invention, and the scope of the invention is outlined by the appended claims.

Claims (5)

1. A polycyclic aromatic hydrocarbon derivative containing a naphthyridine group, characterized by having a structure represented by the following formulae (8) to (13):
Figure FDA0002737247250000011
in the above formulae (8) to (13), Ar1Selected from phenyl, naphthyl, fluorenyl, 9-dimethyl-2-fluorenyl;
Ar2selected from phenyl, naphthyl, H;
l is a single bond;
R3to R13Is selected from H;
R1selected from H, R2Selected from aromatic hydrocarbon groups, condensed ring aromatic hydrocarbon groups;
the aryl is phenyl, o-tolyl, p-tolyl or tert-butylphenyl; the condensed ring aromatic hydrocarbon group is naphthyl, phenanthryl, anthryl, pyrenyl,
Figure FDA0002737247250000013
A fluorenyl group, a triphenylene group or a 9, 9-dimethyl-2-fluorenyl group.
2. A fused ring aromatic hydrocarbon derivative containing a naphthyridine group, wherein the compound has the structure shown below:
Figure FDA0002737247250000012
Figure FDA0002737247250000021
Figure FDA0002737247250000031
3. use of a polycyclic aromatic hydrocarbon derivative containing a naphthyridine group according to claim 1 or 2 in an organic electroluminescent device.
4. The use of a naphthyridine group containing polycyclic aromatic hydrocarbon derivative in an organic electroluminescent device according to claim 3, wherein the naphthyridine group containing polycyclic aromatic hydrocarbon derivative is useful as an electron transport material.
5. An organic electroluminescent device comprises a substrate, and an anode layer, an organic light-emitting functional layer and a cathode layer which are sequentially formed on the substrate; the organic light-emitting functional layer comprises a hole transport layer, an organic light-emitting layer and an electron transport layer, and is characterized in that:
the electron transport material of the electron transport layer is the polycyclic aromatic hydrocarbon derivative containing a naphthyridine group according to claim 1 or 2.
CN201510639887.3A 2015-09-30 2015-09-30 Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof Active CN106554352B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510639887.3A CN106554352B (en) 2015-09-30 2015-09-30 Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510639887.3A CN106554352B (en) 2015-09-30 2015-09-30 Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof

Publications (2)

Publication Number Publication Date
CN106554352A CN106554352A (en) 2017-04-05
CN106554352B true CN106554352B (en) 2020-12-08

Family

ID=58417399

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510639887.3A Active CN106554352B (en) 2015-09-30 2015-09-30 Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof

Country Status (1)

Country Link
CN (1) CN106554352B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108807697B (en) * 2017-04-26 2022-02-22 固安鼎材科技有限公司 Organic electroluminescent device and phenanthrene derivative
CN110878088A (en) * 2018-09-06 2020-03-13 北京鼎材科技有限公司 Compound and application thereof
CN112661760B (en) * 2019-10-16 2023-09-05 北京鼎材科技有限公司 Compound for organic electronic material and organic electroluminescent device containing the same
CN111253393B (en) * 2020-02-05 2022-01-25 北京大学 Long-life triplet exciton confinement material and application thereof in OLED (organic light emitting diode) device
KR20210156913A (en) * 2020-06-18 2021-12-28 솔루스첨단소재 주식회사 Organic light-emitting compound and organic electroluminescent device using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130101449A (en) * 2012-03-05 2013-09-13 (주)씨에스엘쏠라 New dibenzotetracene-based organic electroluminescent compounds and organic electroluminescent device comprising the same
CN105321984A (en) * 2014-08-01 2016-02-10 乐金显示有限公司 Organic light emitting display device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008127446A (en) * 2006-11-20 2008-06-05 Canon Inc 1,5-naphthyridine compound and organic light emitting device
KR20150126526A (en) * 2014-05-02 2015-11-12 삼성디스플레이 주식회사 Organic light emitting device

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130101449A (en) * 2012-03-05 2013-09-13 (주)씨에스엘쏠라 New dibenzotetracene-based organic electroluminescent compounds and organic electroluminescent device comprising the same
CN105321984A (en) * 2014-08-01 2016-02-10 乐金显示有限公司 Organic light emitting display device

Also Published As

Publication number Publication date
CN106554352A (en) 2017-04-05

Similar Documents

Publication Publication Date Title
CN112079834B (en) Organic electroluminescent compound and application thereof
CN106554352B (en) Polycyclic aromatic hydrocarbon derivative containing naphthyridine group and application thereof
CN104650032B (en) A kind of acridine derivatives, its preparation method and its application
CN106554319B (en) Quinazoline group-containing derivative and application thereof
CN104513247B (en) A kind of benzo [ c ] benzo [ 3,4 ] carbazole and carbazole derivates and application
CN113004189B (en) Compound and application thereof
CN110526901A (en) A kind of luminous organic material and its application for preparing organic electroluminescence device
CN104673276A (en) Organic luminescent material and application thereof
CN106554322B (en) Phenazine derivative and application thereof in organic electroluminescent device
CN113402507A (en) Triphenylene derivative, light-emitting device material, and light-emitting device
CN104649954B (en) A kind of phenanthro- carbazole derivates and its application in organic electroluminescence device
CN107663169B (en) 6H-naphtho [2,1,8,7-klmn ] acridine derivative and application thereof
CN106554323B (en) Phenazine group-substituted polycyclic aromatic hydrocarbon derivative and application thereof
CN104672211B (en) A kind of benzacridine derivative, its preparation method and its application
CN110964009B (en) Compound containing phenanthroline structure, application thereof and organic electroluminescent device
CN111233840A (en) Quinoxaline derivative and application thereof in organic light-emitting device
CN111187225B (en) Condensed ring aromatic hydrocarbon derivative with quinoxaline group and application thereof
CN104513192B (en) A kind of benzo anthra [9,1-bc] carbazole derivates and its application
CN104693174B (en) Benzacridine derivant, its preparation method and application thereof
CN104513661B (en) A kind of luminous organic material and its application
CN109678799B (en) Dihydrobenzandazole compound, organic electroluminescent device and display device
CN106558654B (en) Benzophenazine derivative and application thereof in organic electroluminescent device
CN115703784A (en) Indolocarbazole compound with symmetrical structure, application thereof and organic electroluminescent device
CN113444093A (en) Compound and application thereof
CN103788116B (en) Anthracene-based electroluminescent material and application thereof containing imidazoles [1,2-a] pyridine groups

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant